AndroGel heart attack risks will soon be listed on the warning label.
The U.S. Food and Drug Administration (FDA) launched an investigation into the side effects of testosterone drugs in February 2014 after two separate studies suggested that men taking prescription testosterone drugs had an increased risk of suffering a heart attack, stroke or other cardiac event.
Men taking AndroGel to treat low testosterone (Low T) can double their potential risk of suffering a heart attack, according to a 2014 study. A 2013 study published in the Journal of the American Medical Association (JAMA) suggested that older men taking testosterone have a 30 percent increased risk of suffering a heart attack, stroke or death.
The FDA announced on March 3, 2015 that it will require all manufacturers of prescription testosterone drugs to update the warning label to include heart attack and stroke risks. The agency ordered the addition of pulmonary embolism (P.E.) and deep vein thrombosis (DVT) as potential AndroGel side effects in June 2014.
Low T users were led to believe that testosterone would reinvigorate muscles, according to Good Morning America. Sadly, many were left with diminished physical capabilities as a result of suffering a stroke while taking testosterone.
Several men have filed AndroGel lawsuits seeking compensation from Low T manufacturers who failed to warn about the life threatening risks of testosterone drugs.
If you or a loved one suffered heart attack or stroke while using AndroGel you may be eligible for compensation. Contact a testosterone lawyer to find out if you qualify.
Joshua C. Cohan joined Anapol Weiss as an associate in 2013 and is a member of the firm’s Mass Tort Team. His practice focuses on pharmaceutical and medical device mass tort litigation involving complex medical, scientific, and legal issues.